LifePoint Hospitals Stock Rating Reaffirmed by JPMorgan Chase & Co. (LPNT)
LifePoint Hospitals (NASDAQ:LPNT)‘s stock had its “overweight” rating reaffirmed by analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Tuesday. They currently have a $65.00 target price on the stock, up from their previous target price of $62.00. JPMorgan Chase & Co.’s target price points to a potential upside of 6.16% from the stock’s previous close.
LifePoint Hospitals (NASDAQ:LPNT) traded up 1.62% on Tuesday, hitting $62.22. 117,673 shares of the company’s stock traded hands. LifePoint Hospitals has a 52-week low of $43.97 and a 52-week high of $63.07. The stock’s 50-day moving average is $56.84 and its 200-day moving average is $53.79. The company has a market cap of $2.767 billion and a P/E ratio of 22.03. LifePoint Hospitals also was the recipient of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 2,220,858 shares, a decrease of 47.1% from the April 30th total of 4,200,391 shares. Approximately 5.1% of the company’s stock are sold short. Based on an average trading volume of 1,209,464 shares, the days-to-cover ratio is currently 1.8 days.
LifePoint Hospitals (NASDAQ:LPNT) last announced its earnings results on Friday, April 25th. The company reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.65 by $0.13. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1,000.00 million. During the same quarter in the previous year, the company posted $0.79 earnings per share. The company’s revenue for the quarter was up 8.2% on a year-over-year basis. On average, analysts predict that LifePoint Hospitals will post $2.70 earnings per share for the current fiscal year.
A number of other analysts have also recently weighed in on LPNT. Analysts at Mizuho upgraded shares of LifePoint Hospitals from a “neutral” rating to a “buy” rating in a research note on Friday. They now have a $72.00 price target on the stock, up previously from $58.00. Separately, analysts at FBR Capital Markets reiterated a “market perform” rating on shares of LifePoint Hospitals in a research note on Monday, April 28th. They now have a $58.00 price target on the stock. Finally, analysts at Barclays raised their price target on shares of LifePoint Hospitals from $56.00 to $59.00 in a research note on Monday, April 28th. Seven investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. LifePoint Hospitals currently has an average rating of “Hold” and an average price target of $61.14.
LifePoint Hospitals, Inc (NASDAQ:LPNT), through its subsidiaries, operates general acute care hospitals in non-urban communities in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.